Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotoxins up to the present day.

F A Drobniewski1

  • 1St Bartholomew's Hospital Medical College, Charterhouse Square, London.

Bioscience Reports
|April 1, 1989
PubMed
Summary

Immunotoxins link antibodies to toxins for targeted cell killing. This review covers progress in ricin conjugates and discusses future immunolysin applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multidrug-resistant tuberculosis in the United Kingdom and Lithuania.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2014
Same author

Rapid molecular detection of tuberculosis and rifampicin drug resistance: retrospective analysis of a national U.K. molecular service over the last decade.

Thorax·2012
Same author

Human Mycobacterium bovis infections in London and Southeast England.

Journal of clinical microbiology·2011
Same author

Multidrug-resistant tuberculosis: resistance rates to first and reserve antituberculosis drugs in the UK in 2008/9 and the role of rapid molecular tests for drug resistance.

Thorax·2010
Same author

Typing Mycobacterium tuberculosis using variable number tandem repeat analysis.

Methods in molecular biology (Clifton, N.J.)·2010
Same author

The added value of a European Union tuberculosis reference laboratory network--analysis of the national reference laboratory activities.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2008

Area of Science:

  • Biotechnology
  • Immunology
  • Toxicology

Background:

  • Immunotoxins combine antibodies with toxins to target specific cells.
  • Toxins often have an A-B structure, with the A chain being toxic and the B chain mediating cell entry.
  • Current strategies involve conjugating intact toxins or toxin A chains to antibodies.

Purpose of the Study:

  • To review the progress of immunotoxin research, focusing on ricin conjugates.
  • To examine in vitro, in vivo, and clinical studies of immunotoxins.
  • To discuss the potential of immunolysins as future immunotoxin agents.

Main Methods:

  • Literature review of in vitro and in vivo studies.
  • Analysis of recent clinical trial data.
  • Examination of research on membrane-acting toxins.

Main Results:

  • Ricin and ricin A chain conjugates have shown significant progress in research and clinical studies.
  • Different conjugation strategies (intact toxin vs. A chain) are being explored.
  • Immunolysins represent a promising area for future immunotoxin development.

Conclusions:

  • Immunotoxins, particularly ricin-based ones, are advancing in therapeutic applications.
  • Further research into immunolysins could expand the utility of targeted toxin delivery.
  • The field shows potential for developing novel cancer therapies.

Related Experiment Videos